Both POSITION-II and Moore4Medical involve catheter-integrated electronics such as IVUS, FFR, and ICE — technologies that require DYCONEX's core HDI/flex-PCB manufacturing capability.
DYCONEX AG
Swiss manufacturer of miniaturized flex-PCB electronics for smart catheters, implantables, and microfabricated medical devices.
Their core work
DYCONEX AG is a Swiss specialist manufacturer of high-density interconnect (HDI) and flexible printed circuit boards engineered for miniaturized medical electronics. Their core competence lies in producing the precision microelectronic assemblies that make active catheter-based devices work — the tiny, flexible circuits inside intravascular ultrasound (IVUS) probes, fractional flow reserve (FFR) sensors, and intracardiac echocardiography (ICE) catheters used in cardiology cath labs. In EU research projects they serve as a technology supplier and manufacturing partner, contributing microfabrication know-how to consortia building next-generation smart catheters and implantable devices. Their participation in H2020 positions them at the intersection of precision electronics manufacturing and minimally invasive medical device development.
What they specialise in
POSITION-II explicitly targets smart catheters and implants, placing implantable device manufacturing within DYCONEX's confirmed contribution area.
Moore4Medical focuses on accelerating innovation in microfabricated medical devices, where DYCONEX contributes manufacturing process expertise.
Moore4Medical's keywords shift toward 'open and enabling technology platforms', suggesting DYCONEX is broadening its positioning from component supplier toward platform contributor.
How they've shifted over time
In their earlier H2020 engagement (POSITION-II, 2018), DYCONEX's focus was sharply defined around specific cardiology catheter modalities — IVUS, FFR, ICE — reflecting their role as a precision electronics manufacturer for a narrow but high-value segment of interventional cardiology devices. By their second project (Moore4Medical, 2020), the keyword language shifted from specific catheter types toward "open and enabling technology platforms," suggesting a deliberate move to position their manufacturing capabilities as a reusable infrastructure for multiple device classes rather than a single-application supplier. The trajectory points toward DYCONEX seeking broader applicability of their microfabrication know-how across the wider minimally invasive and implantable device landscape.
DYCONEX appears to be evolving from a specialist catheter electronics supplier into a broader medical microfabrication platform partner — organizations building next-generation implantable or minimally invasive devices should find them increasingly relevant beyond cardiology.
How they like to work
DYCONEX joins as a participant, never as project coordinator — consistent with their role as a manufacturing technology contributor rather than a research orchestrator. Their two projects placed them inside very large consortia (90 unique partners across 14 countries for just 2 projects), which indicates they are sought-after specialists brought in to provide a specific industrial capability that few others in a consortium can match. This profile suggests working with them means engaging a focused, execution-oriented partner with deep manufacturing expertise rather than a broad research partner.
Despite only two projects, DYCONEX has touched 90 unique consortium partners spanning 14 countries — an unusually broad network footprint for such a small H2020 portfolio, explained by their participation in two large Innovation Action consortia. Their reach is pan-European with likely strong ties in Germany, the Netherlands, and other medtech manufacturing hubs given the catheter and microfabrication domain.
What sets them apart
DYCONEX occupies a rare industrial niche: a non-academic, Switzerland-based manufacturer with proven capability to build the miniaturized flex-PCB assemblies that make catheter-based diagnostics and therapy possible — a capability that is scarce in EU research consortia that otherwise skew heavily toward universities and research institutes. Their Swiss base also brings access to the dense Swiss medtech and microelectronics ecosystem while remaining fully integrated into EU collaborative research. For a consortium that has a great catheter concept but needs someone who can actually fabricate the electronics at prototype scale, DYCONEX fills a gap that is very hard to replace.
Highlights from their portfolio
- POSITION-IIA pilot line project directly targeting commercialization of next-generation smart catheters and implants — DYCONEX's most application-specific engagement and the clearest window into their core manufacturing domain.
- Moore4MedicalPart of the ECSEL Joint Undertaking's medical electronics initiative, this project represents DYCONEX's move into a broader platform play for microfabricated devices, signaling strategic positioning beyond cardiology catheters.